A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC

Background Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this...

Full description

Saved in:
Bibliographic Details
Published inSurgical endoscopy Vol. 38; no. 10; pp. 5832 - 5841
Main Authors Sautkin, Yaroslaw, Weinreich, Juergen, Reymond, Marc André
Format Journal Article
LanguageEnglish
Published New York Springer US 01.10.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments. Methods The one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution. Results The multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®. Conclusion The multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®. Graphical Abstract
AbstractList Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments. The one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution. The multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®. The multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®.
Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments.BACKGROUNDMulti-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments.The one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution.METHODSThe one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution.The multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®.RESULTSThe multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®.The multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®.CONCLUSIONThe multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®.
Background Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments. Methods The one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution. Results The multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®. Conclusion The multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®. Graphical Abstract
BackgroundMulti-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue drug delivery. Nonetheless, the advantages of such devices over one-nozzle nebulisers have not been demonstrated thus far. In this study, we compared the performance of multi- and one-nozzle nebulisers by conducting physical and ex vivo pharmacological experiments.MethodsThe one-nozzle nebuliser Capnopen® and the multi-nozzle nebuliser were the subjects of this study. In physical experiments, the aerosol droplet size was measured by laser diffraction spectroscopy. Spatial spray patterns were depicted on blotting paper. Pharmacological experiments were performed on the enhanced inverted bovine urinary bladder model, demonstrating real-time tissue drug delivery, aerosol sedimentation and homogeneity of doxorubicin and cisplatin tissue distribution.ResultsThe multi-nozzle nebuliser had a sixfold greater aerosolisation flow and a threefold greater angle of aerosolisation than Capnopen®. The aerosol particle size and distribution range were higher than that of Capnopen®. Spray patterns on blotting paper were more extensive with the multi-nozzle nebuliser. Real-time tissue drug delivery with the multi-nozzle nebuliser was over 100 ml within 1 min, and the aerosol sedimentation was 48.9% ± 21.2%, which was not significantly different from that of Capnopen®. The doxorubicin and cisplatin tissue concentrations were greater with Capnopen®. Although there was no significant difference in the homogeneity of doxorubicin distribution between the two devices, the homogeneity of cisplatin distribution was significantly higher with Capnopen®.ConclusionThe multi-nozzle PIPAC nebuliser did not fulfil expectations. Even though the surface spray patterns were broader with the multi-nozzle nebuliser, the tissue drug homogeneity and concentration were greater with Capnopen®.
Author Weinreich, Juergen
Sautkin, Yaroslaw
Reymond, Marc André
Author_xml – sequence: 1
  givenname: Yaroslaw
  surname: Sautkin
  fullname: Sautkin, Yaroslaw
  email: Yaroslav_sautkin@gmx.de
  organization: National Center for Pleura and Peritoneum, University Hospital Tübingen, Department of General, Visceral and Transplant Surgery, University Hospital Tübingen
– sequence: 2
  givenname: Juergen
  surname: Weinreich
  fullname: Weinreich, Juergen
  organization: National Center for Pleura and Peritoneum, University Hospital Tübingen, Department of General, Visceral and Transplant Surgery, University Hospital Tübingen
– sequence: 3
  givenname: Marc André
  surname: Reymond
  fullname: Reymond, Marc André
  organization: National Center for Pleura and Peritoneum, University Hospital Tübingen, Department of General, Visceral and Transplant Surgery, University Hospital Tübingen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39160309$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u3CAUhVGVqpmkfYEuKqRuuiHlAjawqkaj_kSJlCzaNcIYT4lsmII9UvL0tTtp2mSRFQu-e-6555ygo5iiR-gt0DOgVH4slIpaEMoEAQDJiHiBViA4I4yBOkIrqjklTGpxjE5KuaEzr6F6hY65hppyqlfoYo2HqR8Dienurvc4-mbqQ_EZt8kXHNOIw7DLae_xGEqZPG7ztMWt78Pe51vcTjnELb4-v15vXqOXne2Lf3P_nqIfXz5_33wjl1dfzzfrS-IEq0eiZ4fa8Y5rBm2nXON4oxuopXZOVZKyVnaWS8U62UmwlRK69UppK62SHXf8FH066O6mZvCt83HMtje7HAabb02ywTz-ieGn2aa9ARCVqiuYFT7cK-T0a_JlNEMozve9jT5NxczRCMVAKzGj75-gN2nKcb7PcACuFseL4Lv_LT14-Rv0DLAD4HIqJfvuAQFqljbNoU0zt2n-tGmW3fwwVHZLyj7_2_3M1G9yCKEu
Cites_doi 10.1245/s10434-013-3213-1
10.3762/bjnano.8.272
10.1245/s10434-019-07695-z
10.3390/cancers12010034
10.1080/02656736.2019.1704891
10.1007/s00464-012-2148-0
10.1515/pp-2018-0111
10.1515/pp-2016-0015
10.1515/pp-2019-0017
10.3390/cancers15041125
10.1515/pp-2017-0010
10.1002/pbc.29864
10.1101/2023.03.24.23287646
10.1080/10717544.2021.1937382
10.3390/cancers12030633
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
5PM
DOI 10.1007/s00464-024-11172-4
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-2218
EndPage 5841
ExternalDocumentID PMC11458651
39160309
10_1007_s00464_024_11172_4
Genre Journal Article
Comparative Study
GrantInformation_xml – fundername: Universitätsklinikum Tübingen (8868)
– fundername: Capnopharm GmbH, Tübingen, Germany
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
203
28-
29Q
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAQQT
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z7X
Z82
Z83
Z87
Z88
Z8O
Z8R
Z8V
Z8W
Z91
Z92
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
K9.
7X8
5PM
ID FETCH-LOGICAL-c426t-94329c3f3921df8cbc3b9b1679cc85702d7fa3782f7f71a5849de889a7a87f3c3
IEDL.DBID U2A
ISSN 0930-2794
1432-2218
IngestDate Thu Aug 21 18:35:44 EDT 2025
Mon Jul 21 10:58:37 EDT 2025
Sat Jul 26 00:37:44 EDT 2025
Mon Jul 21 06:02:27 EDT 2025
Tue Jul 01 03:24:20 EDT 2025
Fri Feb 21 02:40:19 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Intraperitoneal drug delivery
Peritoneal metastasis
Pressurised intraperitoneal aerosol chemotherapy—PIPAC
Nebuliser
Peritoneum
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-94329c3f3921df8cbc3b9b1679cc85702d7fa3782f7f71a5849de889a7a87f3c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://link.springer.com/10.1007/s00464-024-11172-4
PMID 39160309
PQID 3113885701
PQPubID 31812
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11458651
proquest_miscellaneous_3094821984
proquest_journals_3113885701
pubmed_primary_39160309
crossref_primary_10_1007_s00464_024_11172_4
springer_journals_10_1007_s00464_024_11172_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-10-01
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Germany
PublicationSubtitle And Other Interventional Techniques
PublicationTitle Surgical endoscopy
PublicationTitleAbbrev Surg Endosc
PublicationTitleAlternate Surg Endosc
PublicationYear 2024
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Giger-Pabst, Bucur, Roger, Falkenstein, Tabchouri, Le Pape, Lerondel, Demtröder, Salamé, Ouaissi (CR4) 2019; 26
Sautkin, Solass, Weinreich, Königsrainer, Schenk, Thiel, Reymond (CR13) 2019; 4
Göhler, Große, Bellendorf, Falkenstein, Ouaissi, Zieren, Stintz, Giger-Pabst (CR14) 2017; 8
de Bree, Michelakis, Stamatiou, Romanos, Zoras (CR2) 2017; 2
Solass, Horvath, Struller, Königsrainer, Beckert, Königsrainer, Weinreich, Schenk (CR18) 2016; 1
Wagner, Adamus, Hempfling, Vahdad, Haap-Hoff, Heinrich, Vázquez, Jank, Denkert, Seitz (CR3) 2022; 69
Sautkin (CR9) 2024
Lee, Kim, Lee, Park, Mun, Paik, Oh, Park, Ryu, Lim, Song, Kim, Lee (CR15) 2020
CR17
Solaß, Hetzel, Nadiradze, Sagynaliev, Reymond (CR7) 2012; 26
Davigo, Passot, Vassal, Bost, Tavernier, Decullier, Bakrin, Alyami, Bonnet, Louzier, Paquet, Allaouchiche, Glehen, Kepenekian (CR6) 2020; 37
Park, Lee, Lee, Kim, Park, Ham, Mun, Paik, Lim, Seol, Yim, Shim, Kang, Chang, Lim, Song, Kim, Lee, Park, Lee, Kim (CR10) 2021; 28
Di Giorgio, Macrì, Ferracci, Robella, Visaloco, De Manzoni, Sammartino, Sommariva, Biacchi, Roviello, Pastorino, PiresMarafon, Rotolo, Casella, Vaira (CR19) 2023
CR12
CR11
Nadiradze, Horvath, Sautkin, Archid, Weinreich, Königsrainer, Reymond (CR1) 2019
Somashekhar, Ashwin, Rauthan, Rohit (CR8) 2019
Solass, Kerb, Mürdter, Giger-Pabst, Strumberg, Tempfer, Zieren, Schwab, Reymond (CR5) 2014; 21
Göhler, Oelschlägel, Ouaissi, Giger-Pabst (CR16) 2023
D Göhler (11172_CR14) 2017; 8
A Di Giorgio (11172_CR19) 2023
E de Bree (11172_CR2) 2017; 2
SJ Park (11172_CR10) 2021; 28
W Solass (11172_CR5) 2014; 21
11172_CR11
W Solass (11172_CR18) 2016; 1
11172_CR12
G Nadiradze (11172_CR1) 2019
I Sautkin (11172_CR9) 2024
D Göhler (11172_CR16) 2023
U Giger-Pabst (11172_CR4) 2019; 26
BR Wagner (11172_CR3) 2022; 69
11172_CR17
I Sautkin (11172_CR13) 2019; 4
HS Lee (11172_CR15) 2020
SP Somashekhar (11172_CR8) 2019
W Solaß (11172_CR7) 2012; 26
A Davigo (11172_CR6) 2020; 37
References_xml – volume: 21
  start-page: 553
  year: 2014
  end-page: 559
  ident: CR5
  article-title: Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-013-3213-1
– volume: 8
  start-page: 2729
  year: 2017
  end-page: 2740
  ident: CR14
  article-title: Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): technical description, experimental validation and first proof of concept
  publication-title: Beilstein J Nanotechnol
  doi: 10.3762/bjnano.8.272
– volume: 26
  start-page: 4445
  year: 2019
  end-page: 4451
  ident: CR4
  article-title: Comparison of tissue and blood concentrations of oxaliplatin administrated by different modalities of intraperitoneal chemotherapy
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-019-07695-z
– year: 2019
  ident: CR1
  article-title: Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12010034
– volume: 37
  start-page: 144
  year: 2020
  end-page: 150
  ident: CR6
  article-title: PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model
  publication-title: Int J Hyperth
  doi: 10.1080/02656736.2019.1704891
– volume: 26
  start-page: 1849
  year: 2012
  end-page: 1855
  ident: CR7
  article-title: Description of a novel approach for intraperitoneal drug delivery and the related device
  publication-title: Surg Endosc
  doi: 10.1007/s00464-012-2148-0
– year: 2019
  ident: CR8
  article-title: Pressurized IntraPeritoneal Aerosol chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer—study protocol for a randomized control trial
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2018-0111
– ident: CR12
– ident: CR17
– ident: CR11
– volume: 1
  start-page: 145
  year: 2016
  end-page: 158
  ident: CR18
  article-title: Functional vascular anatomy of the peritoneum in health and disease
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2016-0015
– volume: 4
  start-page: 20190017
  year: 2019
  ident: CR13
  article-title: A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2019-0017
– year: 2024
  ident: CR9
  publication-title: Quality-by-design optimization of intraperitoneal drug delivery with pressurized aerosols
– year: 2023
  ident: CR19
  article-title: 10 Years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers15041125
– volume: 2
  start-page: 47
  year: 2017
  end-page: 62
  ident: CR2
  article-title: Pharmacological principles of intraperitoneal and bidirectional chemotherapy
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2017-0010
– volume: 69
  start-page: e29864
  year: 2022
  ident: CR3
  article-title: Increasing the efficiency of hyperthermic intraperitoneal chemotherapy (HIPEC) by combination with a photosensitive drug in pediatric rhabdomyosarcoma in an animal model
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.29864
– year: 2023
  ident: CR16
  article-title: Comparative analysis of nebulizers in clinical use for pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  publication-title: medRxiv
  doi: 10.1101/2023.03.24.23287646
– volume: 28
  start-page: 1179
  year: 2021
  end-page: 1187
  ident: CR10
  article-title: Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2021.1937382
– year: 2020
  ident: CR15
  article-title: Evaluation of a novel prototype for pressurized intraperitoneal aerosol chemotherapy
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12030633
– volume: 26
  start-page: 4445
  year: 2019
  ident: 11172_CR4
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-019-07695-z
– volume: 37
  start-page: 144
  year: 2020
  ident: 11172_CR6
  publication-title: Int J Hyperth
  doi: 10.1080/02656736.2019.1704891
– volume: 1
  start-page: 145
  year: 2016
  ident: 11172_CR18
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2016-0015
– ident: 11172_CR12
– ident: 11172_CR17
– ident: 11172_CR11
– volume: 26
  start-page: 1849
  year: 2012
  ident: 11172_CR7
  publication-title: Surg Endosc
  doi: 10.1007/s00464-012-2148-0
– year: 2019
  ident: 11172_CR1
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12010034
– year: 2023
  ident: 11172_CR19
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers15041125
– volume: 69
  start-page: e29864
  year: 2022
  ident: 11172_CR3
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.29864
– volume: 28
  start-page: 1179
  year: 2021
  ident: 11172_CR10
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2021.1937382
– year: 2023
  ident: 11172_CR16
  publication-title: medRxiv
  doi: 10.1101/2023.03.24.23287646
– volume: 21
  start-page: 553
  year: 2014
  ident: 11172_CR5
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-013-3213-1
– volume: 8
  start-page: 2729
  year: 2017
  ident: 11172_CR14
  publication-title: Beilstein J Nanotechnol
  doi: 10.3762/bjnano.8.272
– volume-title: Quality-by-design optimization of intraperitoneal drug delivery with pressurized aerosols
  year: 2024
  ident: 11172_CR9
– year: 2020
  ident: 11172_CR15
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12030633
– volume: 4
  start-page: 20190017
  year: 2019
  ident: 11172_CR13
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2019-0017
– year: 2019
  ident: 11172_CR8
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2018-0111
– volume: 2
  start-page: 47
  year: 2017
  ident: 11172_CR2
  publication-title: Pleura Peritoneum
  doi: 10.1515/pp-2017-0010
SSID ssj0004915
Score 2.4532099
Snippet Background Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity...
Multi-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity of tissue...
BackgroundMulti-nozzle nebulisers for pressurised intraperitoneal aerosol chemotherapy (PIPAC) are implemented in clinical practice to improve the homogeneity...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 5832
SubjectTerms Abdominal Surgery
Administration, Inhalation
Aerosols
Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Bladder
Cattle
Chemotherapy
Cisplatin - administration & dosage
Cisplatin - pharmacokinetics
Cytotoxicity
Doxorubicin - administration & dosage
Doxorubicin - pharmacokinetics
Drug delivery systems
Drug Delivery Systems - instrumentation
Drugs
Endoscopy
Equipment Design
Experiments
Gastroenterology
Gynecology
Hepatology
Lasers
Medicine
Medicine & Public Health
Nebulizers and Vaporizers
Nozzles
Particle Size
Proctology
Spectrum analysis
Surgery
Tissue Distribution
Urinary Bladder
Title A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC
URI https://link.springer.com/article/10.1007/s00464-024-11172-4
https://www.ncbi.nlm.nih.gov/pubmed/39160309
https://www.proquest.com/docview/3113885701
https://www.proquest.com/docview/3094821984
https://pubmed.ncbi.nlm.nih.gov/PMC11458651
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV05T8MwFH6CVkIsiJtyVEZiA0skdhJnTCtKAYEYqARTlMOGSlWC2nSgv55n50DlGJgy2LKTd_h9L-8wwJkGDS56FtTjEaNcoKb7Ul6i4kk0TxFaDKULnO8f3OGI3z47z1VR2KzOdq9DkuakbordTBSOok2hqJ-eTfkqtB3tu6MUj-zgqxrSL-8t8NkltVHcqlKZ39dYNkc_MObPVMlv8VJjhgabsFHhRxKUDN-CFZltw9p9FSHfgbuAmBxBmuWLxUSSTMb6ynM5JWkuZyTLCzI2_xEkKQzNSTqdv5JUTnSCxgcpyxbJ481j0N-F0eDqqT-k1YUJNEFDW1CfM9tPmELMY6VKJHHCYj_WgZYk0Y3s7dRTEUNMoDzlWRFiDz-VQviRFwlPsYTtQSvLM3kAJFIOAgFmKZzKHSeNuWvz1LKY5arY8kQHzmu6he9lX4yw6YBsqBwilUND5ZB34LgmbVjpyCxkuJrQr2V14LQZRunWIYsok_kc56D3KfBQFbjEfsmJZjtdMqwDRB0QSzxqJujO2csj2fjNdNBGJ9ARroMbX9Ts_Hqvvz_j8H_Tj2DdNqKmU_-OoVVM5_IEIUwRd6EdDHq9B_28frm76sJq3-13jRx_Akd06dw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZgSMAF8WYwIEjcINLapG16nCamjT3EgUm7VX0kMGlq0dYd2K_HSbtN43HgXCtJ_ajt2v4CcK-DBhczC-rxkFEu0NJ9KetoeBLdU4geQ-kB5_7AbQ_588gZlTA5ehbmW_3egH26nKInoWiVnk35NuxwzJR1-17Tba5nIP3itgKf1amNSlYOyPy-xqYT-hFZ_myQ_FYlNc6ndQgHZdRIGoWYj2BLpsew2y_r4ifQbRDTGUjTbLGYSJLKSF90LqckyeSMpFlOxubvgSS54TRJpvM3ksiJbsv4JMWwInnpvDSapzBsPb0227S8JoHG6F5z6nNm-zFTGOlYiRJxFLPIj3R5JY41fL2deCpkGAkoT3lWiBGHn0gh_NALhadYzM6gkmapvAASKgfdP7MUknLHSSLu2jyxLGa5KrI8UYWHJd-CjwINI1jhHhsuB8jlwHA54FWoLVkblJYxCxiuJvSxrCrcrR6jTutCRZjKbI40mHMK_JQKXOK8kMRqOz0orMtCVRAbMloRaLzszSfp-N3gZmPq5wjXwY0fl-Jcn-vv17j8H_kt7LVf-72g1xl0r2DfNmqnm_9qUMmnc3mNQUwe3Rjt_QK7yuTB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB2xSIgLYqesRuIGFiR2EudYFSp29QAStyiJbaiEHNSmB_r1jJ00UJYD54xsZ5bMm8xigCMLGkKMLGjEU0a5QEuPlTpDw1PonlL0GNo2ON_dh5eP_PopePrSxe-q3ScpyaqnwU5pMuXpm9SnTeOby8hR9C8UbTXyKZ-FeYxUXKK2E3Y-OyPj6g6DmJ1RH1Wvbpv5fY1p1_QDb_4sm_yWO3UuqbsMSzWWJO1K-Cswo8wqLNzV2fI1uGkTVy9ITTEevypiVGavP1cDIgs1JKYoSd_9U1CkdPwncjB6JlK92mKNd1K1MJLeVa_dWYfH7sVD55LWlyfQHJ1uSWPO_DhnGvGPJ7XIs5xlcWaTLnluh9r7MtIpQ3ygIx15KeKQWCoh4jRKRaRZzjZgzhRGbQFJdYCggHkaSXkQyIyHPpeex7xQZ14kWnA84VvyVs3ISJppyI7LCXI5cVxOeAt2J6xNansZJgxXE_ZYXgsOm8eo6TZ9kRpVjJAGI1GBH1iBS2xWkmi2s-3DNlnUAjElo4bATtGefmL6L26aNgaEgQgD3PhkIs7Pc_39Gtv_Iz-Ahd55N7m9ur_ZgUXfaZ2tCNyFuXIwUnuIbMps3ynvB74p7Qg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+multi-nozzle+nebuliser+does+not+improve+tissue+drug+delivery+during+PIPAC&rft.jtitle=Surgical+endoscopy&rft.au=Sautkin%2C+Yaroslaw&rft.au=Weinreich%2C+Juergen&rft.au=Reymond%2C+Marc+Andr%C3%A9&rft.date=2024-10-01&rft.pub=Springer+US&rft.issn=0930-2794&rft.eissn=1432-2218&rft.volume=38&rft.issue=10&rft.spage=5832&rft.epage=5841&rft_id=info:doi/10.1007%2Fs00464-024-11172-4&rft.externalDocID=10_1007_s00464_024_11172_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0930-2794&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0930-2794&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0930-2794&client=summon